期刊文献+

孕早期Down’s综合征的产前筛查及产前诊断研究 被引量:2

First-trimester prenatal screening and diagnosis for Down's syndrome
暂未订购
导出
摘要 目的 探讨孕早期孕早期Down’s综合征的产前筛查及产前诊断方案。方法 时间分辨荧光免疫法 (TRFIA)对孕 8- 13w的 5 ,4 33例孕妇血清中的 β -hCG、PAPP -A2种血清标记物进行检测 ,筛查出 8例DS胎儿 (通过绒毛染色体核型分析和STR -PCR分析明确诊断 ) ;比较分析 8例DS胎儿母血清与 184例对照病例血清中两种标记物水平。结果 DS组母血中 β-hCG、PAPP -A水平均值分别为 2 .31MoM和 0 .4 2MoM ,与对照组差别有显著性意义 ( P <0 .0 5 ) ;β -hCG、PAPP-A两项指标联合筛查 ,DS的阳性检出率为 75 % ,假阳性率为 8.35 % ;有 7例DS胎儿经绒毛染色体核型分析确诊 ,3例DS胎儿经PCR -STR分析确诊。结论 孕早期 β -hCG、PAPP -A两联标记物筛查DS可以达到孕中期三联标记物筛查效果 ; Objective: To Investigate the performance of first-trimester prenatal screening and diagnosis for Down's syndrome. Methods: Maternal serum were collected from 5433 pregnant women between 8 and 13 weeks gestation ,prior to having a chorionic villus sampling procedure. Free β glycoprotein sub-units of human chorionic gonadotrophin(β-hCG) , pregnancy- associated plasma protein(PAPP-A) were measured using time resolued fluorescence immunoassay (TRFIA). 8 pregnancies women with Down's syndrome were diagnosis using karyotype and polymerase chain reaction with polymorphic short tandem repeat markers (PCR-STR ).The levels of two markers was analyzed between 8 pregnancies women with DS and 184 control pregnancies women. Results: The levels of markers differed between affected and unaffected pregnancies sufficiently.The median freeβ-hCG level in affected pregnancies was 2.31 times the median level for unaffected pregnancies,and the median PAPP-A level was 0.42 times the unaffected median.The combination of the two markers estimate a women's risk of having a fetus with Down's syndrome.A screening programme that used a risk cutoff level of 1:250 would detect 75% 0f affected pregnancies and a 8.35% false- positive rate.Out of affected pregnancies ,7 pregnancies with Down's syndrome were diagnosed using karyotype,3 affected pregnancies were diagnosed using PCR- STR. Conclusion The performance of screening using maternal serum freeβ-hCG and PAPP-A at first-trimester was similar to the triple test at second trimester.The combination of cytogenetics and molecular genetics analyses may provide the success rate and the veracity of prenal diagnosis.
出处 《中国优生与遗传杂志》 2004年第5期42-44,共3页 Chinese Journal of Birth Health & Heredity
基金 河南省医学科技创新人才工程项目 ( 2 0 0 186)
关键词 Down’s综合征 产前筛查 产前诊断 孕早期 Down′s syndrome Prenatal screening Prenatal diagnosis First-trimester
  • 相关文献

参考文献9

  • 1Cuckle HS, Van lith JM. Appropriate biochemical parameters in first - trimester screening for Down syndrome[ J ]. Prenat Diagn, 1999,19(6):505-512.
  • 2Niemimaa M, Suonpaa M, Perheetupa A, et al. Evaluation of first trimester maternal serum and ultrasound screening for Down′s syndrome in Eastern and Norther Finland [ J ]. Eur J Hum Genet,2001,9(6): 101 - 108.
  • 3Holding S. Current state of screening for Down′s syndrome[ J ]. Ann Clin Biochem, 2002, 39(Pt1) P: 1 - 11.
  • 4Bryant LD, Green JM, Newison J. Prenatal screening for Down′s syndrome:Some psychosocial implications of a ′screening for all′ policy[J]. Public Health, 2001, 115(5): 356-358.
  • 5Knight GJ, Palomaki GE, Neveux LM, et al. Clinical validation of new dimeric inhibin- A assay suitable for second trimester Down′s syndrome screening[J] .J Med Screen, 2001.8(1 ) :2-7.
  • 6Holding S. Current state of screening for Down′s syndrome[J]. Ann Clin Biochem, 2002, 39 (Pt1): 1 - 11.
  • 7Wald NJ, George L, Smith D, et al. Serum screening for Down′s syndrome between 8 and 14 weeks of pregnancy[J]. Br J Obstet Gynaecol, 1996, 103:407- 412.
  • 8Baviera G, Corrado F, Carbone C. Prostate - specific antigen in prenatal screening for Down′s syndrome[J]. EurJ Obstet Gynecol Reprod Biol, 2001, 96(2) :238.
  • 9Knight G J, Palomaki GE, Neveux LM, et al. Clinical validation of new dimeric inhibin- A assay suitable for second trimester Down′s syndrome screening[J] .J Med Screen, 2001, 8( 1 ) :2-7.

同被引文献15

  • 1江苏省计划生育委员会出生缺陷干预项目组.中位倍数法及其在产前筛查中的应用[J].中华妇产科杂志,2004,39(6):428-429. 被引量:18
  • 2卓乐雯,廖灿,宋淑本,涂新枝.唐氏综合征产前筛查研究[J].中国实用妇科与产科杂志,2004,20(7):414-416. 被引量:48
  • 3林琳华,任景慧,袁红,李启运,姚秋璇,曾彩兰.妊娠相关血浆蛋白A对唐氏综合征胎儿的筛查价值[J].中国妇幼保健,2005,20(13):1623-1625. 被引量:5
  • 4闫卫东,张霞.21三体综合征及其产前筛查的研究现状和发展方向[J].生物学通报,2005,40(9):17-19. 被引量:11
  • 5Haddow JE, Palomaki GE, Knight GJ, et al. Screening of maternal serum for fetal down~ syndrome in the first trimester [J] . N Engl J Med, 1998, 338 (14) : 955.
  • 6Muller F, Cuckle H, Teisner B, et al. Serum PAPP - A lev- els are depressed in women with fetal Down syndrome in earlypregnancy [J] . Prenat Diagn, 1993, 13 (7) : 633.
  • 7Wald NJ, George L, Smith D, et al. Serum screening for Down~ syndrome between 8 and 14 weeks of pregnancy [J]. Bri J Ob- stet Gynaeeol, 1996,103:407.
  • 8Biagiotti R, Brizn L, Periti E, et al. First trimester screening for Down~ syndrome using maternal serum PAPP - A and free 13- hCG in combination with fetal nuchal translucency thick- ness [J] .Br J Obstet Gynaecol, 1998, 105 (8): 917 - 920.
  • 9何荣霞,李菊香.唐氏综合征的孕早期筛查[J].中国优生优育,2010,16(1):12-13,18.
  • 10Hurley PA, Ward RH, Teisner B, et al. Serum PAPP- A measurements in first - trimester screening for Down syn- drome[J]. Prenat Diagn, 1993,13 (10) : 903.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部